A meta-analysis revealed that apelin levels are higher in patients with type 2 diabetes compared to controls, but plasma apelin concentrations are lower in newly diagnosed and untreated type 2 diabetes patients than in healthy controls 17. The gene discussed is APLN; the disease is type 2 diabetes mellitus.